Authors: Albright, JD Delos Santos, EG Dusza, JP Chan, PS Coupet, J Ru, X Mazandarani, H

Citation: Jd. Albright et al., The synthesis and vasopressin (AVP) antagonist activity of a novel series of N-aroyl-2,4,5,6-tetrahydropyrazolo[3,4-d]thieno[3,2-b]azepines, BIOORG MED, 10(8), 2000, pp. 695-698

Authors: Welmaker, GS Nelson, JA Sabalski, JE Sabb, AL Potoski, JR Graziano, D Kagan, M Coupet, J Dunlop, J Mazandarani, H Rosenzweig-Lipson, S Sukoff, S Zhang, YX

Citation: Gs. Welmaker et al., Synthesis and 5-hydroxytryptamine (5-HT) activity of 2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5-(6H)ones and 2,3,4,4a,5,6-hexahydro-1H-pyrazino[1,2-a]quinoxalines, BIOORG MED, 10(17), 2000, pp. 1991-1994

Authors: Mewshaw, RE Nelson, JA Shah, US Shi, XJ Mazandarani, H Coupet, J Marquis, K Brennan, JA Andree, TH

Citation: Re. Mewshaw et al., New generation dopaminergic agents. 7. Heterocyclic bioisosteres that exploit the 3-OH-phenoxyethylamine D-2 template, BIOORG MED, 9(17), 1999, pp. 2593-2598

Authors: Aranapakam, V Albright, JD Grosu, GT Chan, PS Coupet, J Saunders, T Ru, X Mazandarani, H

Citation: V. Aranapakam et al., 4,10-dihydro-5H-thieno[3,2-c][1]benzazepine derivatives and 9,10-dihydro-4H-thieno[2,3-c][1]benzazepine derivatives as orally active arginine vasopressin receptor antagonists, BIOORG MED, 9(13), 1999, pp. 1733-1736

Authors: Aranapakam, V Albright, JD Grosu, GT Santos, EGD Chan, PS Coupet, J Ru, X Saunders, T Mazandarani, H

Citation: V. Aranapakam et al., 5-fluoro-2-methyl-N-[5-(5H-pyrrolo[2,1-c][1,4] benzodiazepine-10(11H)-YL carbonyl)-2-pyridinyl] benzamide (CL-385004) and analogs as orally active arginine vasopressin receptor antagonists, BIOORG MED, 9(13), 1999, pp. 1737-1740